Suchergebnisse - "Thédrez, Aurélie"

PubPharm (36)

1

FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells

enthalten in: STAR protocols | 2022

von Caillaud, A. | Lévêque, A. | Thédrez, A. | +13

2

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia

enthalten in: Circulation | 2022

von Dijk, W. | Di Filippo, M. | Kooijman, S. | +19

CommentIn: Nat Rev Cardiol. 2022 Oct;19(10):642. - PMID 35978009

3

Corrigendum : PCSK9 is not secreted from mature differentiated intestinal cells

enthalten in: Journal of lipid research | 2022

von Moreau, F. | Thédrez, A. | Garçon, D. | +15

ErratumFor: J Lipid Res. 2021;62:100096. - PMID 34280453

4

Comment on : Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity

enthalten in: Rheumatology (Oxford, England) | 2021

von Heslinga, M. | Lambert, G. | Thédrez, A. | +2

CommentOn: Rheumatology (Oxford). 2021 May 14;60(5):2296-2306. - PMID 33295631

5

Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function

enthalten in: Atherosclerosis | 2021

von Ramin-Mangata, S. | Thedrez, A. | Nativel, B. | +16

6

PCSK9 is not secreted from mature differentiated intestinal cells

enthalten in: Journal of lipid research | 2021

von Moreau, F. | Thédrez, A. | Garçon, D. | +15

ErratumIn: J Lipid Res. 2022 Apr;63(4):100186. - PMID 35298954

7

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes

enthalten in: Atherosclerosis | 2020

von Ramin-Mangata, S. | Wargny, M. | Pichelin, M. | +9

8

PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate

enthalten in: Clinical science (London, England : 1979) | 2018

von Croyal, M. | Tran, T. | Blanchard, R. | +16

9

Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor) : Implications for the Efficacy of Evolocumab

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2018

von Thedrez, A. | Blom, D. | Ramin-Mangata, S. | +11

CommentIn: Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):481-483. - PMID 29467219

10

Plasma PCSK9 measurement by liquid chromatography-Tandem mass spectrometry and comparison with conventional ELISA

enthalten in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2017

von Croyal, M. | Fall, F. | Krempf, M. | +9